These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28507200)
21. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner. Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825 [TBL] [Abstract][Full Text] [Related]
22. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204 [TBL] [Abstract][Full Text] [Related]
23. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase. Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598 [TBL] [Abstract][Full Text] [Related]
24. Cyanobacterial lectins characteristics and their role as antiviral agents. Singh RS; Walia AK; Khattar JS; Singh DP; Kennedy JF Int J Biol Macromol; 2017 Sep; 102():475-496. PubMed ID: 28437766 [TBL] [Abstract][Full Text] [Related]
25. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors. Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883 [TBL] [Abstract][Full Text] [Related]
27. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library. Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486 [TBL] [Abstract][Full Text] [Related]
28. [Structure and Function of a Novel Class of High Mannose-binding Proteins with Anti-viral or Anti-tumor Activity]. Sato Y Yakugaku Zasshi; 2015; 135(11):1281-9. PubMed ID: 26521877 [TBL] [Abstract][Full Text] [Related]
29. Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus. Pastuch-Gawolek G; Chaubey B; Szewczyk B; Krol E Eur J Med Chem; 2017 Sep; 137():247-262. PubMed ID: 28601004 [TBL] [Abstract][Full Text] [Related]
30. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus. Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957 [TBL] [Abstract][Full Text] [Related]
31. Unusual entropy-driven affinity of Chromobacterium violaceum lectin CV-IIL toward fucose and mannose. Pokorná M; Cioci G; Perret S; Rebuffet E; Kostlánová N; Adam J; Gilboa-Garber N; Mitchell EP; Imberty A; Wimmerová M Biochemistry; 2006 Jun; 45(24):7501-10. PubMed ID: 16768446 [TBL] [Abstract][Full Text] [Related]
33. Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors. Chen D; Cai J; Yin J; Jiang J; Jing C; Zhu Y; Cheng J; Di Y; Zhang Y; Cao M; Li S; Peng Z; Hao X Future Med Chem; 2015; 7(5):561-70. PubMed ID: 25921398 [TBL] [Abstract][Full Text] [Related]
34. Deciphering molecular properties and docking studies of hepatitis C and non-hepatitis C antiviral inhibitors - A computational approach. Venkatesan A; Febin Prabhu Dass J Life Sci; 2017 Apr; 174():8-14. PubMed ID: 28259653 [TBL] [Abstract][Full Text] [Related]
35. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine. Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593 [TBL] [Abstract][Full Text] [Related]
36. Benzohydroxamic acids as potent and selective anti-HCV agents. Kozlov MV; Kleymenova AA; Romanova LI; Konduktorov KA; Smirnova OA; Prasolov VS; Kochetkov SN Bioorg Med Chem Lett; 2013 Nov; 23(21):5936-40. PubMed ID: 24035094 [TBL] [Abstract][Full Text] [Related]
37. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity. Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209 [TBL] [Abstract][Full Text] [Related]
38. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry. Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693 [TBL] [Abstract][Full Text] [Related]